Depression and Anxiety Trial, Recruiting NCT05011864 Sponsor: University of Texas at Austin Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT05011864
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 50 or older
  • People who are proficient in English or Spanish
  • People who score above 15 on a 28-question depression rating scale called the Hamilton Rating Scale for Depression, indicating moderate to severe depression symptoms
  • People who score above 4 on a 12-question fall risk questionnaire, indicating a higher risk of falling

Who may not be able to join:

  • People who started or changed their antidepressant medication within the last 4 weeks
  • People who are considered to be at high risk of suicide
  • People who show signs that suggest they may have dementia
  • People who have been diagnosed with bipolar disorder
  • People who have a current issue with substance use or misuse
  • People who are currently taking part in any talk therapy or fall prevention program
  • People who are unable to get out of bed and are confined to bed full-time

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Namkee G Choi, University of Texas at Austin

Phone: 5122329590

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Texas at Austin
Registry
ClinicalTrials.gov
Start date
1 November 2021
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Changes from baseline depressive symptom at 12, 24, and 36 weeks; Changes from baseline fall count and injury at 12, 24, and 36 weeks; Changes from baseline EuroQol-5D score at 12, 24, and 36 weeks; Changes from baseline physical and mental health service use; Changes from baseline disability score at 12, 24, and 36 weeks; Changes from baseline social engagement and activities score at 12, 24, and 36 weeks; Changes from baseline satisfaction with social roles & activities at 12, 24, and 36 weeks

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov